Results 91 to 100 of about 657,034 (319)
ATLAS events at 13 TeV - 2016 conferences [PDF]
, 2016 The ATLAS collaboration has released in 2016 an impressive number of results using data collected at 13 TeV. Some of the corresponding event displays are grouped here for media and press. The reference to the conference note is given in the caption. Read
ATLAS Collaboration
core
Translating whole‐genome doubling into precision medicine in cancer
Molecular Oncology, EarlyView.Whole‐genome doubling creates a WGD‐positive tumor state characterized by persistent chromosomal instability, karyotypic diversification, and cellular stress. These same biological pressures drive aggressive tumor evolution while exposing therapeutic vulnerabilities, providing a rationale for WGD‐informed precision medicine. Whole‐genome doubling (WGD)
Sejung Lee, Junghyeok Lim, Jinhyuk Bhin
wiley +1 more source
Molecular Oncology, EarlyView.Single‐cell DNA methylation (scDNAme) profiling maps epimutational clonal evolution, revealing mechanisms of malignancy and therapeutic resistance across diverse cancer types. By providing a high‐resolution landscape of intratumoral heterogeneity, these technologies empower precise patient stratification, guide the development of enhanced ...
Ik Soo Kim
wiley +1 more source
The Turkish Journal of Ear Nose and ThroatObjective: Sarcopenia, which increases with age, causes a decrease in muscle mass and strength, potentially leading to changes in the voice’s acoustic, perceptual, and aerodynamic parameters, as well as dysphagia. This study aimed to assess the voice and
Serkan Bengisu, Aynur İkra Demir
doaj +1 more source
Map showing countries in the ATLAS collaboration [PDF]
, 2014 Map showing countries in the ATLAS ...
ATLAS, Experiment
core
Molecular Oncology, EarlyView.Interferon type 1 (IFN‐1) production and signaling is associated with the acquisition of therapy resistance, following chronic DNA damage, via Interferon‐related DNA damage resistance signature (IRDS) gene expression. An alternative, DNA damage‐independent role of sustained IFN‐1 mediated resistance was identified and characterized by the emergence of ...
Ashlyn Conant +11 more
wiley +1 more source
Spatial biology in cancer epigenetics
Molecular Oncology, EarlyView.Spatial epigenomics combines molecular profiling with tissue architecture to reveal how gene regulation is organized within intact tissues. In cancer, these technologies uncover the mechanisms driving tumor heterogeneity and microenvironmental interactions, opening new opportunities for biomarker discovery and precision medicine.
Eva Crespo‐García, Manel Esteller
wiley +1 more source
BMC NutritionAim This cross-sectional study compared hedonic hunger, body image, and nutrition knowledge between individuals with prior metabolic–bariatric surgery (MBS) whose current BMI was 18.5–24.9 kg/m² and individuals with BMI 18.5–24.9 kg/m² without prior MBS.
Ayşe Betül Bilen +5 more
doaj +1 more source
FEBS Open Bio, EarlyView.Chemotherapy side effects significantly impact cancer survivors' quality of life. Using protein levels in blood samples from breast cancer patients before and after 12 weeks of taxane treatment, we detected treatment‐dependent changes in calcium signaling and aging pathways associated with cancer recurrence.
Saira Munshani +6 more
wiley +1 more source
FEBS Open Bio, EarlyView.A novel signature integrating genome‐wide analysis with clinical factors predicts recurrence in stage II colorectal cancer and enables a new risk stratification to guide postoperative adjuvant chemotherapy. Clinical risk stratification for postoperative recurrence in patients with pathological stage II (pStage II) colorectal cancer (CRC) is essential ...
Mayuko Otomo +7 more
wiley +1 more source